Op­tiBi­otix signs Tai­wan li­cence deal

Yorkshire Post - Business - - BUSINESS / NEWS -

Health: Op­tiBi­otix Health, a life sciences business de­vel­op­ing com­pounds to tackle obe­sity, high choles­terol, di­a­betes and skin care, has an­nounced that it has en­tered into a three-year non-ex­clu­sive li­cence agree­ment with Bened Bio­med­i­cal in Tai­wan.

The agree­ment grants Bened a non-ex­clu­sive li­cense to pro­duce, mar­ket, and com­mer­cialise prod­ucts con­tain­ing Op­tiBi­otix’s choles­terol and blood pres­sure re­duc­ing strain.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.